Samsara BioCapital’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Samsara BioCapital’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,034,552	Closed	-$2.44M	–	43
2023 Q4	$2.44M	Hold	2,034,552	–	–	0.38%	29
2023 Q3	$1.75M	Hold	2,034,552	–	–	0.54%	29
2023 Q2	$2.44M	Sell	2,034,552 -226,100	-10%	-$1.13M	0.43%	27
2023 Q1	$19.8M	Hold	2,260,652	–	–	4.08%	6
2022 Q4	$18.1M	Buy	2,260,652 +700,000	+45%	+$4.4M	3.89%	6
2022 Q3	$7.62M	Hold	1,560,652	–	–	1.78%	16
2022 Q2	$8.68M	Sell	1,560,652 -10,727	-0.7%	-$36.8K	2.31%	12
2022 Q1	$7.97M	Hold	1,571,379	–	–	2.01%	12
2021 Q4	$20.2M	Hold	1,571,379	–	–	3.93%	8
2021 Q3	$23.5M	Sell	1,571,379 -65,929	-4%	-$1.12M	3.69%	9
2021 Q2	$25.4M	Buy	+1,637,308	New	+$28.7M	3.14%	10

Samsara BioCapital's RAIN Position: Q1 2024 in Review

Samsara BioCapital sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 2,034,552 shares — an estimated $2.44M sold.

Samsara BioCapital first reported a position in RAIN in Q2 2021 and held it in 11 quarters. The position peaked at $25.4M in Q2 2021. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

Samsara BioCapital reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Samsara BioCapital sold 2,034,552 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $2.44M.
Samsara BioCapital first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 11 quarters.
Samsara BioCapital's Rain Oncology Inc. Common Stock position peaked at $25.4M in Q2 2021.
0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Samsara BioCapital's 13F filing for Q1 2024, filed 15 May 2024.